Deuterium Metabolic Imaging for 3D Mapping of Glucose Metabolism in Humans with Central Nervous System Lesions at 3T

Overview

Journal Magn Reson Med

Publisher Wiley

Specialty Radiology

Date 2023 Oct 5

PMID 37796151

Authors

Philip M Adamson

Keshav Datta

Ron Watkins

Lawrence D Recht

Ralph E Hurd

Daniel M Spielman

Affiliations

Soon will be listed here.

Abstract

Purpose: To explore the potential of 3T deuterium metabolic imaging (DMI) using a birdcage H radiofrequency (RF) coil in both healthy volunteers and patients with central nervous system (CNS) lesions.

Methods: A modified gradient filter, home-built H volume RF coil, and spherical k-space sampling were employed in a three-dimensional chemical shift imaging acquisition to obtain high-quality whole-brain metabolic images of H-labeled water and glucose metabolic products. These images were acquired in a healthy volunteer and three subjects with CNS lesions of varying pathologies. Hardware and pulse sequence experiments were also conducted to improve the signal-to-noise ratio of DMI at 3T.

Results: The ability to quantify local glucose metabolism in correspondence to anatomical landmarks across patients with varying CNS lesions is demonstrated, and increased lactate is observed in one patient with the most active disease.

Conclusion: DMI offers the potential to examine metabolic activity in human subjects with CNS lesions with DMI at 3T, promising for the potential of the future clinical translation of this metabolic imaging technique.

Citing Articles

Lipid removal in deuterium metabolic imaging (DMI) using spatial prior knowledge.

de Graaf R, Liu Y, Corbin Z, De Feyter H Magn Reson (Gott). 2025; 5(1):21-31.

PMID: 39980872 PMC: 11836565. DOI: 10.5194/mr-5-21-2024.

Deuterium Metabolic Imaging Enables the Tracing of Substrate Fluxes Through the Tricarboxylic Acid Cycle in the Liver.

Ehret V, Durr S, Ustsinau U, Friske J, Scherer T, Furnsinn C NMR Biomed. 2024; 38(1):e5309.

PMID: 39676029 PMC: 11646830. DOI: 10.1002/nbm.5309.

Simultaneous assessment of cerebral glucose and oxygen metabolism and perfusion in rats using interleaved deuterium (H) and oxygen-17 (O) MRS.

Zhang G, Jenkins P, Zhu W, Chen W, Zhu X NMR Biomed. 2024; 38(1):e5284.

PMID: 39503302 PMC: 11602644. DOI: 10.1002/nbm.5284.

Deuterium Metabolic Imaging of Alzheimer Disease at 3-T Magnetic Field Strength: A Pilot Case-Control Study.

Khan A, Peterson K, Vittay O, McLean M, Kaggie J, OBrien J Radiology. 2024; 312(1):e232407.

PMID: 39012255 PMC: 11294762. DOI: 10.1148/radiol.232407.

Deuterium metabolic imaging for 3D mapping of glucose metabolism in humans with central nervous system lesions at 3T.

Adamson P, Datta K, Watkins R, Recht L, Hurd R, Spielman D Magn Reson Med. 2023; 91(1):39-50.

PMID: 37796151 PMC: 10841984. DOI: 10.1002/mrm.29830.

References

Fan A, Khalil A, Fiebach J, Zaharchuk G, Villringer A, Villringer K . Elevated brain oxygen extraction fraction measured by MRI susceptibility relates to perfusion status in acute ischemic stroke. J Cereb Blood Flow Metab. 2019; 40(3):539-551. PMC: 7026852. DOI: 10.1177/0271678X19827944. View

Beinat C, Haywood T, Chen Y, Patel C, Alam I, Murty S . The Utility of [F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography. Mol Imaging Biol. 2018; 20(6):1015-1024. DOI: 10.1007/s11307-018-1194-y. View

Beinat C, Patel C, Haywood T, Murty S, Naya L, Castillo J . A Clinical PET Imaging Tracer ([F]DASA-23) to Monitor Pyruvate Kinase M2-Induced Glycolytic Reprogramming in Glioblastoma. Clin Cancer Res. 2021; 27(23):6467-6478. PMC: 8639752. DOI: 10.1158/1078-0432.CCR-21-0544. View

Kreis F, Wright A, Hesse F, Fala M, Hu D, Brindle K . Measuring Tumor Glycolytic Flux in Vivo by Using Fast Deuterium MRI. Radiology. 2019; 294(2):289-296. DOI: 10.1148/radiol.2019191242. View

Papandreou I, Goliasova T, Denko N . Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?. Int J Cancer. 2010; 128(5):1001-8. DOI: 10.1002/ijc.25728. View

Vlassenko A, McConathy J, Couture L, Su Y, Massoumzadeh P, Leeds H . Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors. Dis Markers. 2015; 2015:874904. PMC: 4573613. DOI: 10.1155/2015/874904. View

Cho A, Lau J, Geraghty B, Cunningham C, Keshari K . Noninvasive Interrogation of Cancer Metabolism with Hyperpolarized C MRI. J Nucl Med. 2017; 58(8):1201-1206. PMC: 6944182. DOI: 10.2967/jnumed.116.182170. View

Batsios G, Taglang C, Tran M, Stevers N, Barger C, Gillespie A . Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer. Clin Cancer Res. 2022; 28(16):3526-3536. PMC: 9378519. DOI: 10.1158/1078-0432.CCR-21-4418. View

Chesnelong C, Chaumeil M, Blough M, Al-Najjar M, Stechishin O, Chan J . Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro Oncol. 2013; 16(5):686-95. PMC: 3984548. DOI: 10.1093/neuonc/not243. View

10.

Malloy C, Merritt M, Sherry A . Could 13C MRI assist clinical decision-making for patients with heart disease?. NMR Biomed. 2011; 24(8):973-9. PMC: 3174329. DOI: 10.1002/nbm.1718. View

11.

De Feyter H, de Graaf R . Deuterium metabolic imaging - Back to the future. J Magn Reson. 2021; 326:106932. PMC: 8083995. DOI: 10.1016/j.jmr.2021.106932. View

12.

Corbin Z . New metabolic imaging tools in neuro-oncology. Curr Opin Neurol. 2019; 32(6):872-877. DOI: 10.1097/WCO.0000000000000758. View

13.

Hamilton J, Franson D, Seiberlich N . Recent advances in parallel imaging for MRI. Prog Nucl Magn Reson Spectrosc. 2017; 101:71-95. PMC: 5927614. DOI: 10.1016/j.pnmrs.2017.04.002. View

14.

Smeitink J, Zeviani M, Turnbull D, Jacobs H . Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab. 2006; 3(1):9-13. DOI: 10.1016/j.cmet.2005.12.001. View

15.

Goldenberg J, Pagel M . Assessments of tumor metabolism with CEST MRI. NMR Biomed. 2018; 32(10):e3943. PMC: 7377947. DOI: 10.1002/nbm.3943. View

16.

Baron J, Jones T . Oxygen metabolism, oxygen extraction and positron emission tomography: Historical perspective and impact on basic and clinical neuroscience. Neuroimage. 2012; 61(2):492-504. DOI: 10.1016/j.neuroimage.2011.12.036. View

17.

de Graaf R, Hendriks A, Klomp D, Kumaragamage C, Welting D, Arteaga de Castro C . On the magnetic field dependence of deuterium metabolic imaging. NMR Biomed. 2019; 33(3):e4235. PMC: 7141779. DOI: 10.1002/nbm.4235. View

18.

Seth P, Grant A, Tang J, Vinogradov E, Wang X, Lenkinski R . On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate. Neoplasia. 2011; 13(1):60-71. PMC: 3022429. DOI: 10.1593/neo.101020. View

19.

von Morze C, Merritt M . Cancer in the crosshairs: targeting cancer metabolism with hyperpolarized carbon-13 MRI technology. NMR Biomed. 2018; 32(10):e3937. PMC: 6281789. DOI: 10.1002/nbm.3937. View

20.

Adamson P, Datta K, Watkins R, Recht L, Hurd R, Spielman D . Deuterium metabolic imaging for 3D mapping of glucose metabolism in humans with central nervous system lesions at 3T. Magn Reson Med. 2023; 91(1):39-50. PMC: 10841984. DOI: 10.1002/mrm.29830. View